Adze Biotechnology
Coral Gables, US · Founded 2018 · Delaware corporation
Find your way into Adze Biotechnology
Sign up to see every warm intro you have to Adze Biotechnology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Adze Biotechnology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SH
Sidney HoppsDirector and President/CEO
KT
Kenneth TemplinDirector, Secretary and Treasurer/CFO
RS
Richard SchulerNamed on SEC filing
PG
Patrick G. Sage, IINamed on SEC filing
Board
BK
Brendan KennyBoard director
GR
Gabriel RavivBoard director
GP
G. Patrick Sage, IIBoard director
Reported raises · per SEC filings
Form D private placements$9.8M disclosed across 2 rounds · 2019–2023
▶$6.2MraisedNov 2025 · 21 investors · BiotechnologyRule 506(c)
▶$6.2MraisedNov 2025 · 21 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Brendan KennyDirector
- Sidney HoppsExecutive Officer, Director
- Gabriel RavivDirector
- G. Patrick Sage, IIDirector
- Offering amount
- $15M
- Amount sold
- $6.2M
- Minimum investment
- $25K
- Proceeds to insiders
- $300K
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$3.7MraisedMay 2022 · 19 investors · BiotechnologyRule 506(c)
▶$3.7MraisedMay 2022 · 19 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Richard SchulerDirector
- Patrick G. Sage, IIDirector
- Kenneth TemplinExecutive Officer, Director
- Gabriel RavivDirector
- Sidney HoppsExecutive Officer, Director
- Offering amount
- $3.7M
- Amount sold
- $3.7M
- Minimum investment
- $30K
- Finders' fees
- $140K
- Proceeds to insiders
- $175K
- Placement agents
- Stuart Cornew, Craig R. McWilliams
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Adze Biotechnology raised?
- Adze Biotechnology has disclosed $9.8M raised across 2 rounds.
- Where is Adze Biotechnology headquartered?
- Adze Biotechnology is headquartered in Coral Gables, US.